The Effects of Sacubitril/Valsartan Compared to Olmesartan on the Blood Pressure and Glucolipid Metabolism in DM Patients with Primary Hypertension
CardiologiaSobre o estudo
- Desenho
- Ensaio clínico randomizado
- Nível de evidência
- 2 · Nova evidência
- Revista
- Cardiovascular drugs and therapy
- Publicado em
- 13 out 2023
- Citações
- 6
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
The Effects of Sacubitril/Valsartan Compared to Olmesartan on the Blood Pressure and Glucolipid Metabolism in DM Patients with Primary Hypertension
Shuang Zhang, Zheng Yin, Zhi-Fan Li, Wen-Jia Zhang, Yong-Gang Sui, Yan-Lu Xu, Hai-Tao Zhang, Xiao-Ning Liu, Hong Qiu, Jing-Lin Zhao et al.
Descritores MeSH
- Valsartan
- Aminobutyrates
- Antihypertensive Agents
- Biphenyl Compounds
- Blood Pressure
- Drug Combinations
- Hypertension
- Imidazoles
- Tetrazoles
- Humans
Veja também
Estudos relacionados
- Sacubitril/valsartan role in patients with resistant hypertension: a systematic review
- Efficacy and Safety Comparative of Sacubitril/Valsartan vs. Olmesartan in the Treatment of hypertension: A Meta-analysis of RCTs
- Efficacy and Safety of Sacubitril/Valsartan in Chronic Type B Aortic Dissection Combined With Mild Hypertension
- Comparison of sacubitril/valsartan with olmesartan for hypertension: A meta-analysis of randomized controlled trials